Jean Jacques Bienaime - Dec 10, 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Dec 10, 2021
Transactions value $
-$554,820
Form type
4
Date filed
12/17/2021, 06:03 PM
Previous filing
Oct 22, 2021
Next filing
Jan 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Gift $0 -700 -0.23% $0.00 304K Dec 10, 2021 Direct F1
transaction BMRN Common Stock Options Exercise $225K +6K +1.98% $37.46 310K Dec 15, 2021 Direct F2
transaction BMRN Common Stock Sale -$496K -6K -1.94% $82.71 304K Dec 15, 2021 Direct F2
transaction BMRN Common Stock Options Exercise $225K +6K +1.98% $37.46 310K Dec 16, 2021 Direct F2
transaction BMRN Common Stock Sale -$508K -6K -1.94% $84.68 304K Dec 16, 2021 Direct F2
holding BMRN Common Stock 248K Dec 10, 2021 Shares held by Jean-Jacques Bienaime Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -6K -4.38% $0.00 131K Dec 15, 2021 Common Stock 6K $37.46 Direct F2, F3
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -6K -4.58% $0.00 125K Dec 16, 2021 Common Stock 6K $37.46 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 10, 2021 the reporting person gifted 700 shares to an educational institution.
F2 Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.
F3 Reflects the number of options outstanding after the transactions from this specific stock option grant.